search
Drug Recommendation System
Trends
- 1Medium-severity flaw disclosed in SourceCodester Drug Recommendation Systemโผ๐จ EUVD-2026-97757 ๐ Score: 5.3/10 (CVSS v3.1) ๐ฆ Product: Drug Recommendation System ๐ข Vendor: SourceCodester ๐ Updated:
A vulnerability tracked as EUVD-2026-97757 has been disclosed in SourceCodester's Drug Recommendation System 1.0, scoring 5.3 out of 10 on the CVSS v3.1 scale. The weakness sits in an unknown function of a file within the application, and details were updated on 12 October 2026. Security feeds are circulating the advisory, though the vendor has not been named as having issued a fix.
- 2Security flaw reported in SourceCodester Drug Recommendation System 1.0โผ๐จ EUVD-2026-97759 ๐ Score: 5.3/10 (CVSS v3.1) ๐ฆ Product: Drug Recommendation System ๐ข Vendor: SourceCodester ๐ Updated:
A vulnerability tracked as EUVD-2026-97759 has been reported in SourceCodester's Drug Recommendation System 1.0, a web application distributed by the vendor. The flaw involves an unknown function of one of the application's files and carries a moderate CVSS v3.1 score of 5.3 out of 10. Details remain limited, and security observers are flagging it as another example of the type of weakness frequently found in small-vendor PHP applications.
- 3VA and Pentagon Guideline Backs Semaglutide and Tirzepatide for ObesityโผNew VA/DoD Obesity Guideline Strongly Recommends Semaglutide, Tirzepatide
The Department of Veterans Affairs and Department of Defense have issued a new obesity guideline that strongly recommends GLP-1 medications semaglutide and tirzepatide for weight management in veterans and service members. The recommendation is drawing attention because it signals growing official acceptance of newer weight-loss drugs and could influence care for millions of patients across the military health system.